PetMed Express Inc. (PETS) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$0.12	-$0.28	-333.3%	—	$41M	—
Q4 26	-$0.18	-$0.19	-5.6%	—	$42.8M	—
Q3 26	-$0.06	-$0.5	-733.3%	—	$40.7M	—
Q2 26	$0.04	-$0.41	-1125.0%	—	$44.4M	—
Q3 25	$0.01	-$0.03	-400.0%	—	$53M	—
Q2 25	-$0.05	$0.11	+320.0%	—	$59.6M	—
Q1 25	-$0.09	$0.18	+300.0%	—	$68M	—
Q4 24	—	-$0.25	—	—	$66.5M	—
Q1 24	$0.07	-$0.04	-157.1%	—	$78.2M	—
Q4 23	$0.14	-$0.25	-278.6%	—	$62.4M	—
Q3 23	$0.17	$0.02	-88.2%	—	$58.9M	—
Q2 23	$0.25	$0.13	-48.0%	—	$65.4M	—
Q1 23	$0.25	$0.14	-44.0%	—	$70M	—
Q4 22	$0.26	$0.3	+15.4%	—	$66M	—
Q3 22	$0.3	$0.21	-30.0%	—	$60.7M	—
Q2 22	$0.35	$0.31	-11.4%	—	$67.4M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	-$2.74	—	—	$179M	—
FY25	—	-$0.3	—	—	—	—
FY24	—	-$0.37	—	—	$274.1M	—
FY23	—	$0.25	—	—	$256.6M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$249.2M	$273.8M	$283.4M	$284.1M	$303.6M	$272.3M	$256.6M	$274.1M	—	$179M
YoY change	+6.18%	+9.88%	+3.51%	+0.25%	+6.85%	-10.3%	-5.77%	+6.83%	—	—

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	249.2M	273.8M	283.4M	284.1M	303.6M	272.3M	256.6M	274.1M	—	179M
Cost of revenue	169.9M	176M	188.1M	202.9M	219.3M	195.3M	185.8M	189.3M	—	128.8M
Gross profit	79.3M	97.8M	95.3M	81.2M	84.3M	76.9M	70.7M	84.8M	—	50.2M
Gross margin	31.8%	35.7%	33.6%	28.6%	27.8%	28.3%	27.6%	30.9%	—	28.1%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	40.5M	43.5M	46.9M	48M	51.4M	49.9M	61.1M	85.9M	—	72.2M
Operating expenses	40.5M	43.5M	46.9M	48M	51.4M	49.9M	61.1M	85.9M	—	72.2M
Operating income	37.5M	52.1M	46.2M	31M	30.5M	24.3M	6.1M	-8.2M	—	-31.4M
Operating margin	15%	19%	16.3%	10.9%	10.1%	8.92%	2.36%	-2.98%	—	-17.5%
Non-operating income, net	300K	995K	1.1M	1.2M	1.3M	1M	944K	1.4M	—	-26.5M
Pretax income	37.9M	53.8M	49.1M	33.9M	30.9M	24.2M	7.4M	-6.3M	—	-57.4M
Income tax	14.1M	16.5M	11.4M	8M	7M	5.5M	2.3M	1.2M	—	-73K
Net income	23.8M	37.3M	37.7M	25.9M	23.9M	18.7M	5.1M	-7.5M	—	-57.3M
Net margin	9.56%	13.6%	13.3%	9.1%	7.88%	6.87%	2%	-2.72%	—	-32%
EBITDA	38.9M	54.3M	48.4M	33.2M	33M	27M	9.6M	-1.1M	—	5.2M
EPS	1.18	1.83	1.84	1.29	1.53	1.05	0.25	-0.37	-0.3	-2.74
Diluted EPS	1.17	1.82	1.84	1.29	1.52	1.04	0.25	-0.37	-0.3	-2.74

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	78.2M	71M	65.3M	66.5M	68M	59.6M	53M	51.2M	44.4M	40.7M	42.8M	41M
Cost of revenue	55.7M	50.9M	47.4M	48.3M	50M	42.3M	38.1M	36.8M	31.9M	31.2M	28.9M	29.7M
Gross profit	22.5M	20.1M	17.9M	18.2M	18M	17.3M	14.9M	14.4M	12.4M	9.5M	13.9M	11.3M
Gross margin	28.8%	28.3%	27.4%	27.3%	26.4%	29.1%	28.1%	28.1%	28%	23.3%	32.6%	27.6%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	23M	17.5M	19.2M	20.1M	11.9M	15.1M	13.8M	19M	18.5M	17.5M	17.2M	15.4M
Operating expenses	23M	17.5M	19.2M	20.1M	11.9M	15.1M	13.8M	19M	18.5M	17.5M	17.2M	15.4M
Operating income	-2.1M	875K	-3.1M	-3.8M	4.4M	554K	-450K	-6.9M	-8.4M	-10.5M	-5.7M	-6.2M
Operating margin	-2.72%	1.23%	-4.71%	-5.77%	6.45%	0.93%	-0.85%	-13.4%	-18.9%	-25.7%	-13.3%	-15.2%
Non-operating income, net	506K	254K	293K	325K	231K	186K	180K	-27.1M	195K	148K	273K	438K
Pretax income	-1.4M	1.3M	-2.6M	-3.5M	4.7M	925K	-242K	-34.1M	-8.5M	-10.5M	-4.2M	-6.1M
Income tax	-292K	565K	-618K	1.5M	958K	-1.4M	465K	9K	9K	11K	-102K	13K
Net income	-1.1M	715K	-2M	-5M	3.8M	2.3M	-707K	-34.2M	-8.5M	-10.6M	-4.1M	-6.1M
Net margin	-1.45%	1.01%	-3.1%	-7.54%	5.52%	3.9%	-1.33%	-66.7%	-19.2%	-26%	-9.48%	-15%
EBITDA	-450K	2.6M	-1.3M	-1.9M	6.1M	2.2M	1.1M	22.7M	-6.1M	-8.1M	-3.3M	-4.1M
EPS	-0.06	0.04	-0.1	-0.25	0.18	0.11	-0.03	-1.65	-0.41	-0.5	-0.19	-0.28
Diluted EPS	-0.06	0.03	-0.1	-0.25	0.18	0.11	-0.03	-1.65	-0.41	-0.5	-0.19	-0.28

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	407.5M	849.4M	466.1M	576.8M	705.5M	520.5M	329.3M	97.7M	86.3M	47.7M	30.6M
Enterprise value	348.7M	771.5M	365.6M	473M	586.8M	409.5M	225.2M	43.9M	86.3M	26.8M	19.6M
Shares outstanding	20.2M	20.3M	20.5M	20M	20.1M	20.2M	20.3M	20.4M	20.6M	20.9M	20.9M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	17.1	22.8	12.4	22.3	29.5	27.8	64.1	—	—	—	257
P/S	1.64	3.1	1.64	2.03	2.32	1.91	1.28	0.36	—	0.27	0.19
P/B	4.36	7.34	3.46	4.44	4.99	4.22	2.99	1.01	—	1.65	1.35
EV/EBITDA	8.98	14.2	7.55	14.2	17.8	15.1	23.5	-39.7	—	5.13	-1.05
EV/Sales	1.4	2.82	1.29	1.66	1.93	1.5	0.88	0.16	—	0.15	0.12
Earnings yield	5.85%	4.39%	8.1%	4.48%	3.39%	3.6%	1.56%	—	—	—	0.39%
FCF yield	8.98%	4.32%	9.55%	6.33%	5.34%	3.22%	6.85%	-0.2%	—	-69.2%	-52.2%
PEG	—	—	—	—	—	—	—	—	—	—	-3.1

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	31.8%	35.7%	33.6%	28.6%	27.8%	28.3%	27.6%	30.9%	—	28.1%	27.6%
Operating margin	15%	19%	16.3%	10.9%	10.1%	8.92%	2.36%	-2.98%	—	-17.5%	-15.2%
Net margin	9.56%	13.6%	13.3%	9.1%	7.88%	6.87%	2%	-2.72%	—	-32%	-17.3%
ROE	25.5%	32.2%	28%	19.9%	16.9%	15.2%	4.67%	-7.72%	—	-197.9%	-78.6%
ROA	21.1%	27.7%	24.4%	16.6%	12.8%	10.4%	3.07%	-4.39%	—	-70.6%	-20%
ROIC	68%	95.6%	103.9%	90%	104.6%	152%	71%	-19%	—	-389.6%	-298.1%
Return on tangible assets	21.3%	27.8%	24.6%	16.7%	12.8%	10.5%	3.1%	-7.93%	—	-81.6%	-55%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	4.46	5.81	6.79	5.3	3.59	2.68	2.27	1.3	—	0.84	0.68
Quick ratio	3.35	4.52	5.64	4.57	2.82	2.11	1.94	0.9	—	0.58	0.47
Debt / equity	—	—	—	—	—	—	0	0.02	—	0.02	0.02
Debt / assets	—	—	—	—	—	—	0	0.01	—	0.01	0.01
Net debt / EBITDA	—	—	—	—	—	—	-10.8	48.7	—	-3.99	0.59
Effective tax rate	37.2%	30.7%	23.2%	23.7%	22.7%	22.6%	31%	0%	—	0%	0%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	12.3	13.5	13.9	14.2	15.1	13.5	12.7	13.4	—	8.56	7.98
EPS (basic)	1.18	1.83	1.84	1.29	1.53	1.05	0.25	-0.37	-0.3	-2.74	-2.74
EPS (diluted)	1.17	1.82	1.84	1.29	1.52	1.04	0.25	-0.37	-0.3	-2.74	-1.37
Book value per share	4.61	5.69	6.58	6.49	7.04	6.12	5.42	4.74	—	1.38	1.09
FCF per share	1.81	1.8	2.18	1.82	1.88	0.83	1.11	-0.01	—	-1.58	-1.28
Cash per share	2.9	3.83	4.91	5.18	5.92	5.51	5.13	2.71	—	1.02	0.62
Capex per share	0.52	0.03	0.03	0.12	0.12	0.09	0.26	0.22	—	—	—

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	4.26%	0.26%	0.22%	0.81%	0.8%	0.64%	2.05%	1.65%	—	—	—
Capex / operating cash flow	24%	1.84%	1.35%	6.39%	7.4%	11.2%	21.2%	104.2%	—	—	—
Payout ratio	65.1%	46.9%	58.1%	84.3%	94.8%	130.3%	477.4%	-166.6%	—	-0.04%	0%
Dividend yield	3.81%	2.06%	4.7%	3.78%	3.22%	4.68%	7.45%	12.7%	—	0.04%	85.7%

Yield

85.7%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.30

ex-dividend Aug 11, 2023

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 11, 2023	$0.30
Jun 5, 2023	$0.30
Feb 16, 2023	$0.30
Nov 17, 2022	$0.30
Aug 11, 2022	$0.30
May 19, 2022	$0.30
Feb 4, 2022	$0.30

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Revenue	$78.2M	$71M	$65.3M	$66.5M	$68M	$59.6M	$53M	$51.2M	$44.4M	$40.7M	$42.8M	$41M
YoY change	+11.7%	+8.57%	+11%	+6.56%	-13.2%	-16.1%	-18.9%	-24.7%	-25.5%	-23.3%	—	-19.9%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY26
Cash & short-term investments	37.6M	58.7M	77.9M	100.5M	103.8M	118.7M	111.1M	104.1M	55.3M	21.4M
Receivables	1.7M	1.8M	2.3M	2.5M	3.8M	2.6M	1.9M	1.7M	3.3M	1.9M
Inventory	25.6M	20.2M	23.3M	21.4M	17.9M	34.4M	32.5M	19M	28.6M	13.6M
Total current assets	67.6M	81.8M	105.2M	126.4M	129M	161.2M	151M	130.4M	93.6M	43.6M
Property, plant & equipment	5.9M	12.6M	10.9M	9.3M	7.6M	7.6M	6.6M	7.3M	8.6M	7.3M
Goodwill & intangibles	860K	860K	860K	860K	860K	860K	860K	1.7M	75.7M	11M
Total assets	90.3M	112.8M	134.8M	154.4M	155.3M	187.5M	179.7M	167.5M	169.9M	81.2M
Accounts payable	5M	15.2M	15.3M	16.3M	19.7M	39.5M	27.5M	25.2M	37M	20.9M
Short-term debt	—	—	—	—	—	—	—	—	459K	493K
Total current liabilities	7.1M	18.4M	18.1M	18.6M	24.3M	44.9M	56.2M	57.5M	72.2M	52M
Long-term debt	—	—	—	—	—	—	—	0	995K	42K
Total liabilities	7.1M	19.4M	19.1M	19.7M	25.3M	46.2M	56.2M	57.5M	73.2M	52.3M
Shareholders' equity	83.2M	93.4M	115.7M	134.7M	130M	141.3M	123.5M	110M	96.7M	28.9M
Total debt	—	—	—	—	—	—	—	0	1.5M	535K
Net debt	—	—	—	—	—	—	—	-104.1M	-53.8M	-20.9M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Cash & short-term investments	61.5M	53.5M	49.4M	55.3M	46M	52M	50.1M	41.1M	36.1M	26.9M	21.4M	13.1M
Receivables	1.9M	2.2M	1.9M	3.3M	2.3M	1.6M	2.3M	1.6M	2M	1.6M	1.9M	1.7M
Inventory	32.3M	18.9M	34.6M	28.6M	25.5M	13.1M	11.8M	18.4M	14.8M	12.2M	13.6M	8.5M
Total current assets	105.8M	85.7M	95.5M	93.6M	77.6M	70.8M	68.4M	67.9M	59.5M	48.5M	43.6M	27.6M
Property, plant & equipment	29.2M	28.8M	28.4M	8.6M	27.4M	27.4M	29.5M	29.7M	29.1M	28.2M	7.3M	25.6M
Goodwill & intangibles	66.8M	69.3M	76.7M	75.7M	74.7M	73.8M	72.8M	13.9M	12.9M	12M	11M	10.5M
Total assets	180.7M	159.3M	173.3M	169.9M	152.7M	146M	144.8M	109.8M	100.3M	88M	81.2M	63.8M
Accounts payable	40M	25.4M	38.9M	37M	24.5M	17M	10.9M	20M	19.1M	20.3M	20.9M	12.3M
Short-term debt	799K	757K	752K	459K	438K	446K	453K	469K	477K	485K	493K	414K
Total current liabilities	57.3M	40.7M	72.4M	72.2M	58.3M	48.8M	48M	57.6M	56.7M	54.8M	52M	40.6M
Long-term debt	1.3M	1.1M	890K	995K	883K	768K	652K	414K	291K	167K	42K	0
Total liabilities	62.4M	45.6M	73.3M	73.2M	59.2M	49.6M	48.6M	58.3M	57.2M	55.2M	52.3M	40.8M
Shareholders' equity	118.3M	113.7M	100.1M	96.7M	93.5M	96.4M	96.2M	51.5M	43.1M	32.8M	28.9M	23M
Total debt	2.1M	1.8M	1.6M	1.5M	1.3M	1.2M	1.1M	883K	768K	652K	535K	414K
Net debt	-59.5M	-51.6M	-47.8M	-53.8M	-44.7M	-50.8M	-49M	-40.2M	-35.3M	-26.3M	-20.9M	-12.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY26
Net income	20.6M	23.8M	37.3M	37.7M	25.9M	23.9M	18.7M	5.1M	-7.5M	-57.3M
Depreciation & amortization	770K	1.4M	2.1M	2.2M	2.3M	2.4M	2.7M	3.5M	7.1M	9.4M
Stock-based compensation	1.6M	1.9M	2.6M	3.1M	2.8M	3.3M	4.5M	6.6M	6.9M	1.4M
Change in working capital	-720K	15.1M	-3.7M	2.6M	5.4M	4.5M	-9.6M	11.1M	-2.4M	-3.1M
Operating cash flow	22.2M	44.1M	38.2M	45.8M	36.2M	32.9M	15.6M	24.8M	4.3M	-28.4M
Capital expenditure	-20.1M	-10.6M	-703K	-620K	-2.3M	-2.4M	-1.8M	-5.3M	-4.5M	—
Investing cash flow	-4.5M	-10.6M	-703K	-620K	-2.3M	-2.4M	-1.8M	-10.3M	-40.7M	0
Dividends paid	-14.7M	-15.5M	-17.5M	-21.9M	-21.8M	-22.7M	-24.4M	-24.5M	-12.4M	-21K
Share repurchases	—	—	0	0	-11.5M	0	0	—	—	—
Financing cash flow	-14.5M	-15.5M	-17.5M	-21.9M	-33.3M	-22.7M	-24.4M	-24.5M	-12.4M	-299K
Net change in cash	3.2M	18M	20.1M	23.3M	545K	7.7M	-10.6M	-10M	-48.8M	-28.7M
Free cash flow	923K	36.6M	36.7M	44.5M	36.5M	37.6M	16.7M	22.5M	-194K	-33M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27
Net income	-1.1M	—	—	-5M	3.8M	—	—	—	-8.5M	-10.6M	-4.1M	-6.1M
Depreciation & amortization	1.7M	—	—	1.9M	1.7M	—	—	—	2.3M	2.4M	2.4M	2.1M
Stock-based compensation	1.8M	—	—	1.7M	-8.2M	—	—	—	248K	254K	272K	198K
Change in working capital	-872K	326K	-504K	2.1M	-9.1M	-496K	-494K	-977K	2.2M	4M	-3.4M	-3.3M
Operating cash flow	803K	326K	-504K	1.4M	-11.9M	-496K	-494K	-977K	-2.2M	-9.2M	-4.7M	-7.7M
Capital expenditure	-1.2M	—	—	-1.3M	-683K	—	—	—	—	—	—	—
Investing cash flow	-37M	—	—	-1.3M	-683K	—	—	—	—	—	—	—
Dividends paid	-6.1M	—	—	-18K	-104K	—	—	—	-22K	-1K	3K	0
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-6.1M	—	—	-18K	-104K	—	—	—	-231K	0	-38K	-5K
Net change in cash	-42.3M	326K	-504K	122K	-12.6M	-496K	-494K	-977K	-2.4M	-9.2M	-4.8M	-7.7M
Free cash flow	-591K	—	—	5.9M	-9.2M	—	—	—	-4.8M	-9.2M	-5.5M	-8.3M

PetMed Express Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history